Christophe Prehaud
Mansfield University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christophe Prehaud.
Research in Veterinary Science | 1995
Geneviève Libeau; Christophe Prehaud; Renaud Lancelot; François Colas; L. Guerre; D.H.L. Bishop; Adama Diallo
A competitive ELISA based on the reaction between a monoclonal antibody (mAb) and a recombinant nucleoprotein of the peste des petits ruminants virus (PPRV) was developed. This protein was obtained in large quantities from insect cells infected with a PPR nucleoprotein recombinant baculovirus (N-B). The competitive ELISA was compared with the virus neutralisation test (VNT) for detecting specific antibodies to PPRV in sheep and goats. The time consuming VNT is the only prescribed test that is capable of distinguishing between PPRV and the cross-reactive rinderpest virus (RPV). The competitive ELISA involves the simultaneous addition of the mAb and antibodies present in a positive serum, leading to competition for a specific epitope on the N-B. Optimum conditions were obtained by using serum samples which had positive or negative neutralising activity against PPRV or RPV. A negative cut-off point was determined on PPRV-negative sera from RPV-vaccinated cattle. A threshold value of 48 per cent inhibition, calculated from the mean for this population plus 2.7 standard deviations, was used in routine testing. A total of 683 sera were analysed by the competitive ELISA and the VNT. A good correlation (r = 0.94) was observed between the titres obtained in the two tests, with 80 sera that were from laboratory sources. The agreement between the two tests was determined on 271 field sera (kappa = 0.825). Their relative sensitivity (94.5 per cent) and specificity (99.4 per cent) were assessed on the 148 laboratory sera plus the 271 sera used for the determination of kappa.(ABSTRACT TRUNCATED AT 250 WORDS)
Virology | 1991
Michael A. Whitt; Linda Buonocor; Christophe Prehaud; John K. Rose
The spike glycoprotein (G protein) of rabies virus (CVS strain) expressed in HeLa cells from cloned cDNA mediated membrane fusion after exposure to pHs of 6.1 or below. Chemical crosslinking showed that the rabies G protein, like the vesicular stomatitis virus (VSV) G protein, could be crosslinked to dimers and trimers, indicating that rabies G protein is a trimer. However, unlike the VSV G protein, rabies G protein trimers were not stable to sedimentation in sucrose gradients, even at a mildly acidic pH which stabilizes the VSV G protein trimers. In addition, we report that the expressed rabies virus G protein was functional because it could assemble into VSV particles (tsO45) lacking VSV G protein and rescue infectivity. These VSV (rabies) pseudotypes were neutralized only by an antibody to the rabies G protein. We also examined the properties of a hybrid protein containing the extracellular domain of the rabies virus glycoprotein and the transmembrane and cytoplasmic domains of the VSV G protein. This protein was transported to the cell surface and could be crosslinked to form dimers and trimers, but had little or no detectable membrane fusion activity. The lack of fusion activity was paradoxical because the hybrid protein could rescue VSV infectivity, although the titers were lower than those obtained with the wild-type rabies G protein.
Virology | 1989
Christophe Prehaud; Kazuaki Takehara; Anne Flamand; David H.L. Bishop
The gene encoding the glycoprotein of rabies virus (G protein, CVS strain) has been cloned and inserted into the baculovirus transfer vector pAcYM1 derived from the nuclear polyhedrosis virus of Autographa californica (AcNPV). The gene was placed under the control of the AcNPV polyhedrin promoter and expressed to high levels by the derived recombinant virus using a Spodoptera frugiperda cell line. It has been established that the antigenic characteristics of the protein were conserved by comparison with those of the native glycoprotein of rabies virions. The immunogenicity of the expressed product was also demonstrated. Intraperitoneal or intramuscular injection of G antigen conferred protection to mice and was associated with the induction of high titers of neutralizing antibodies. The availability of large quantities of antigenically and immunogenically reactive rabies G protein may make feasible crystallographic studies and the safe preparation of a low cost subunit vaccine for the disease.
Virology | 1990
Christophe Prehaud; Raymond D Harris; Vilmos Fulop; Chong-Lek Koh; Joseph Wong; Anne Flamand; David H.L. Bishop
A baculovirus expression vector (AcNPV3) derived from the nuclear polyhedrosis virus of Autographa californica (AcNPV) was prepared containing the complete coding region of the nucleoprotein (N) gene of rabies virus (Gif-sur-Yvette clone of the CVS strain). The gene was placed under the control of the AcNPV polyhedrin promoter and was expressed to high levels (66 mg N protein/liter of 2 x 10(9) cells) by the derived recombinant virus using a Spodoptera frugiperda cell line. Using available antisera, it was established that the antigenic characteristics of the N protein were similar by comparison with those of the native N protein of rabies virus. Characterization of the expressed protein established that, like the N protein of mammalian cell-grown CVS virus, the N protein was phosphorylated. The expressed rabies N protein induced antibodies in mice that reacted strongly with the rabies viral protein. The expressed nucleoprotein was recovered from the insect cells by differential centrifugation followed by ion exchange chromatography. The expressed rabies N protein represents a source of authentic protein suitable for virus diagnosis as well as structural studies.
Virology | 1992
Christophe Prehaud; Karen Nel; David H.L. Bishop
The rabies N, M1, M2, and G antigens have been expressed in Spodoptera frugiperda cells from single gene expression vectors or dual gene vectors (N/M1 or M2/G) using the baculovirus system. Although N protein was phosphorylated, no evidence for M1 phosphorylation was obtained. N-M1 complexes were formed in vivo using dual infections or the coexpression vectors, as well as in vitro in mixing experiments. The free or complexed rabies N and M1 proteins reacted with available monoclonal and polyclonal antibodies. By sedimentation analyses the N-M1 complexes were shown to exist in multiple configurations.
The Lancet | 1997
Jacques P. Amblard; Paul Obiang; Samuel Edzang; Christophe Prehaud; Michèle Bouloy; Bernard Le Guenno
Nucleic Acids Research | 1992
Rolf Muller; C. Argentini; Michèle Bouloy; Christophe Prehaud; David H.L. Bishop
Nucleic Acids Research | 1991
Rolf Muller; Claudio Argentini; Michèle Bouloy; Christophe Prehaud; David H.L. Bishop
Archive | 1997
Christophe Prehaud; Michèle Bouloy
Archive | 1989
Patrice Coulon; Claude Derbin; Paul Kucera; Florence Lafay; Christophe Prehaud